Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

MRK - Merck & Co., Inc.


Close
100.98
0.240   0.238%

Share volume: 8,168,081
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.28%

PREVIOUS CLOSE
CHG
CHG%

$100.74
1.73
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 2023-05-05 2023-08-07 2023-11-03 2024-02-26 2024-05-03 2024-08-05 2024-11-06
Total revenue 14.487 B 15.035 B 15.962 B 14.631 B 15.775 B 16.112 B 16.657 B
Cost of revenue 3.926 B 4.024 B 4.264 B 3.912 B 3.540 B 3.745 B 4.080 B
Gross profit 10.561 B 11.011 B 11.698 B 10.719 B 12.235 B 12.367 B 12.577 B
    4.26% 6.24% -8.37% 14.14% 1.08% 1.70%  
Operating expenses 6.755 B 16.023 B 5.826 B 12.431 B 6.475 B 6.239 B 8.593 B
Selling general and admin 2.479 B 2.702 B 2.519 B 2.804 B 2.483 B 2.739 B 2.731 B
Research and development 4.276 B 13.321 B 3.307 B 9.627 B 3.992 B 3.500 B 5.862 B
Total expenses 10.681 B 20.047 B 10.090 B 16.343 B 10.015 B 6.319 B 8.649 B
    87.69% -49.67% 61.97% -38.72% -36.90% 36.87%  
Operating income 3.806 B -5.012 B 5.872 B -1.712 B 5.760 B 6.048 B 3.928 B
Ebit 3.806 B -5.012 B 5.872 B -1.712 B 5.760 B 6.006 B 4.090 B
Pretax income 3.650 B -5.335 B 5.620 B -2.046 B 5.670 B 6.006 B 4.090 B
    -246.16% -205.34% -136.41% -377.13% 5.93% -31.90%  
Income tax 825.000 M 637.000 M 870.000 M -820.000 M 903.000 M 545.000 M 929.000 M
Net income basic 2.821 B -5.975 B 4.745 B -1.226 B 4.762 B 0.000 0.000
    -311.80% 179.41% -125.84% 488.42% -100.00%    
Net income 2.821 B -5.975 B 4.745 B -1.226 B 4.762 B 5.461 B 3.161 B
    -311.80% 179.41% -125.84% 488.42% 14.68% -42.12%